Skip to Content

Notice

Memorandum of Understanding by and Between the United States Food and Drug Administration and the International Anesthesia Research Society for the Safety of Key Inhaled and Intravenous Drugs in Pediatrics Public-Private Partnership

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the International Anesthesia Research Society (IARS). The purpose of this MOU is to establish a framework for collaboration between FDA and IARS and to support their shared interest of promoting the safe use of anesthetics and sedatives in children.

DATES:

The agreement became effective March 21, 2010.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Wendy R. Sanhai, Senior Scientific Advisor, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 4128, Silver Spring, MD 20993, 301-796-8518.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

Start Signature

Dated: May 26, 2010.

Leslie Kux,

Acting Assistant Commissioner for Policy.

End Signature Start Printed Page 31451

Start Printed Page 31452

Start Printed Page 31453

Start Printed Page 31454

Start Printed Page 31455

Start Printed Page 31456

Start Printed Page 31457

End Supplemental Information

BILLING CODE 4160-01-S

[FR Doc. 2010-13292 Filed 6-2-10; 8:45 am]

BILLING CODE 4160-01-C